Table of Contents
Chapter One: Executive Summary
- Scope
- Revolution in Disease Treatment
- Market Summary
- The Pipeline
Chapter two: Introduction
- Definitions
- Molecular Imaging
- Molecular Imaging Agents
- Imaging Modalities
- Nuclear Pharmaceuticals
- MI Agent Research
- Collaborations and Synergy Needed
chapter three: Promising Technologies and
- Applications
- Overview
- SPECT
- Alzheimers Disease
- Serotonin Reuptake Inhibitor
- Folate Receptor-Positive Cancers
- Computed Tomography
- Imaging Cell Death
- Bone Evaluation
- Imaging Critical Blood Flow
- Super Paramagnetic Agents
- Metastatic Lymph Nodes
- Iron Oxide Nanoparticles
- Microbubbles
- Gene Expression
- Strategies for Cancer
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Latent Heart Disease
- The Source of Infection
Chapter Four: Research and Development Methodology and Strategies
Chapter Five: Market Analysis
- Market Size and Growth
- Movement into the Radiology Laboratory
- Evaluating Treatment Efficacy
- SPECT and Gamma Cameras
- New Market for Gamma Cameras
- New Market Opportunities
- Significant Market for Alzheimers Disease
- The Impact of Ultrasound Imaging Agents
- Competitive Landscape
- Market Drivers
- Aging Population Drives Imaging Utilization
- Increased Functionality of Products
- Need for Digitization
- Novel Contrast Agents
- Market Restraints
- Maturity Limits Opportunities
- Rapid Pace of Innovation Restricts Spending
- Market Consolidation
Chapter Six: Company Profiles
- Advanced Magnetics
- Alerion Biomedical
- AnorMED
- Boston Life Sciences
- Cytogen
- Epix Pharmaceuticals
- Mallinckrodt
Appendix: References
list of exhibits
Chapter One: Executive Summary
- Exhibit 1: Market Summary: Sales of Imaging Agents* United States and World 2003-2009
- Exhibit 2: Market Summary: U.S. Sales of Molecular Imaging Equipment by Modality 2004-2009
Chapter two: Introduction
- Exhibit 3: Representative Molecular Imaging Agents in Common Use
- Exhibit 4: In Vivo Molecular Imaging Modalities and Their Approximate Sensitivities
- Exhibit 5: Table of Common Radionuclides
- Exhibit 6: Selected Examples of Contrast Media and Complimentary Imaging Modalities
Chapter Five: Market Analysis
- Exhibit 7: U.S. Sales of Molecular Imaging Equipment by Modality (Ultrasound, SPECT & SPECT/CT Combinations, MRI, and PET & PET/CT Combinations) 2004-2009
- Exhibit 8: U.S. and Worldwide Sales of Imaging Agents 2003-2009
- Exhibit 9: Molecular Imaging Agents Currently Available for Magnetic Resonance and Ultrasound (Manufacturer, Agent Name, and Modality)
- Exhibit 10: Estimated Potential Peak Yearly U.S Usage for Selected New Imaging Agents (Manufacturer, Product, Use, Peak Procedure Estimate)
- Exhibit 11: Number of U.S Imaging Procedures by Modality 2003-2009
- Exhibit 12: U.S Gamma Camera Market Shipments and Installed Base 2004
View Cart
